PATENT CLAIM ANALYSIS

Application Number: 15542848
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-01
Patent Classification: ["544", "262000"]

Abstract:
Described herein is the synthesis of Bruton's tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo [3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one.

Claim (Index 2):
The process of  claim 1  for the preparation of 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (ibrutinib), wherein ibrutinib is the compound of Formula (I), comprising reacting; the compound of Formula (II) with phenylboronic acid:

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.2963
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16073809', '14957294', '14450068', '15836482', '16074505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7641817481362769
- 35 USC 102 Novelty (BERT): 0.5461513013623407
- Combined Prediction Score: 0.7423787034588833
- Mean Citation Score: 389.038508
- Max Citation Score: 426.1503
- Similarity Product: 318.5898453648448

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test